To test this, we investigated the expression of PTEN, β-catenin, and EBP50, with reference to epithelial–mesenchymal transition (EMT)- and cancer stem cell (CSC)-like features, using Em Ca cell lines and clinical samples. The gene discussed is PTEN; the disease is cancer.